Zhang, Jun http://orcid.org/0000-0001-7886-6187
Veeramachaneni, Nirmal
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (N/A)
Article History
Received: 5 October 2021
Accepted: 3 November 2021
First Online: 27 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: JZ has served as a scientific advisor/consultant for: AstraZeneca; Biodesix; Novocure; Bayer; Daiichi Sankyo; Mirati; Novartis; Cardinal Health; Bristol Myers Squibb; Nexus Health, and Sanofi. JZ has also received research funding from AstraZeneca, Biodesix, Novartis, Genentech/Roche, Mirati, AbbVie, and Hengrui Therapeutics. NV has served as a consultant for Medtronic.